drugset / Trial / NCT07343245

A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs

NCT07343245

Phase 1 Recruiting 150 enrolled Daewon Pharmaceutical Co., Ltd.
RandomizedParallel-groupOpen-labelBasic science

Summary

Drug-Drug Interaction between DW4421 and three different kinds of NSAIDs

Timeline

Start
2025-12-01
Primary completion
2026-02-22
Completion
2026-06-17

Drugs

EvaluationDrugModalityDoseRoute
Subject DW4421 Unknown
Subject DW4421-N1 Unknown
Subject DW4421-N2 Unknown
Subject DW4421-N3 Unknown

Indications

No indication recorded.